title: Synergism Between Anticholinergic and Oxime Treatments Against Sarin-Induced Ocular Insult in Rats.
abstract: Eye exposure to the extremely toxic organophosphorus sarin results in long-term miosis and visual impairment. As current treatment using atropine or homatropine eye drops may lead to considerable visual side effects, alternative combined treatments of intramuscular (im) oximes (16.8 µmol/kg, im) with atropine (0.5 mg/kg, im) or with the short acting antimuscarinic tropicamide (0.5%; w/v) eye drops were thus evaluated. The combined treatments efficacy following topical exposure to sarin (1 µg) was assessed by measuring pupil width and light reflex using an infra-red based digital photographic system. Results showed that the combined treatment of various oximes with atropine or with topical tropicamide eye drops rapidly reversed the sarin-induced miosis and presented a long-term improvement of 67-98% (oxime+tropicamide) or 84-109% (oxime+atropine) in pupil widening as early as 10-min following treatment. This recovery was shown to persist for at least 8-h following exposure. All combined treatments facilitated the ability of the iris to contract following sarin insult as tested by a light reflex response.Our findings emphasize the high efficacy of im oxime treatment combined with either atropine im or tropicamide eye drops in counteracting sarin-induced ocular insult. Therefore, in a mass casualty scenario the systemic combined treatment may be sufficient to ameliorate sarin-induced ocular insult with no need for additional, topical anticholinergic treatment at least in the initial stage of intoxication. For very mild casualties, who are unlikely to receive im treatment, the combined oxime (im) with topical tropicamide treatment may be sufficient in ameliorating the ocular insult.
authors.affiliation: Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, 74100, Israel Arielg@iibr.gov.il.
authors.forename: A
authors.initials: A
authors.lastname: Gore
authors.affiliation: Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, 74100, Israel.
authors.forename: R
authors.initials: R
authors.lastname: Brandeis
authors.affiliation: Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, 74100, Israel.
authors.forename: I
authors.initials: I
authors.lastname: Egoz
authors.affiliation: Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, 74100, Israel.
authors.forename: J
authors.initials: J
authors.lastname: Turetz
authors.affiliation: Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, 74100, Israel.
authors.forename: U
authors.initials: U
authors.lastname: Nili
authors.affiliation: Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, 74100, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Grauer
authors.affiliation: Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, 74100, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Bloch-Shilderman
mesh_terms: D060433:Administration, Ophthalmic; D000818:Animals; D001285:Atropine / Q000494:pharmacology* / Q000627:therapeutic use; D002801:Cholinesterase Reactivators / Q000494:pharmacology*; D004357:Drug Synergism; D005123:Eye / Q000187:drug effects*; D008297:Male; D015877:Miosis / Q000188:drug therapy; D010091:Oximes / Q000494:pharmacology*; D051381:Rats; D020318:Rats, Long-Evans; D012524:Sarin / Q000633:toxicity*; D014331:Tropicamide / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D002801:Cholinesterase Reactivators; D010091:Oximes; D001285:Atropine; D012524:Sarin; D014331:Tropicamide
keywords: HI-6; Long-Evans rats, miosis; MMB-4; TMB-4; anticholinergic treatments; atropine; obidoxime; organophosphates; oxime; pupillary light reflex; sarin; tropicamide